A Study to Assess the Safety and Efficacy of LB-P8 in Patients With PSC
Public ClinicalTrials.gov record NCT06699121. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2 Randomized, Double Blind, Placebo Controlled, Parallel Study Evaluating the Safety and Efficacy of LB P8 in Patients With Primary Sclerosing Cholangitis (PSC)
Study identification
- NCT ID
- NCT06699121
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- LISCure Biosciences
- Industry
- Enrollment
- 87 participants
Conditions and interventions
Conditions
Interventions
- LB-P8 high-dose Drug
- LB-P8 low-dose Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 2025
- Primary completion
- Feb 29, 2028
- Completion
- Jan 31, 2029
- Last update posted
- Oct 23, 2025
2025 – 2029
United States locations
- U.S. sites
- 7
- U.S. states
- 7
- U.S. cities
- 7
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of California Davis | Sacramento | California | 95817 | Not yet recruiting |
| UCHealth University of Colorado Hospital | Aurora | Colorado | 80045 | Not yet recruiting |
| University Of Iowa Hospitals And Clinics | Iowa City | Iowa | 52242 | Recruiting |
| Mercy Medical Center | Baltimore | Maryland | 21202 | Recruiting |
| Mayo Clinic | Rochester | Minnesota | 55905 | Not yet recruiting |
| The Vanderbilt Clinic | Nashville | Tennessee | 37232 | Recruiting |
| Liver institute Northwest | Seattle | Washington | 98105 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06699121, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 23, 2025 · Synced May 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06699121 live on ClinicalTrials.gov.